Golden Finance reports that Nasdaq plans to delist BNB treasury company Windtree Therapeutics (stock code: WINT) due to the company's failure to comply with Nasdaq listing rule 5550(a)(2) — which requires the stock's minimum bid to remain above $1. Windtree confirmed its non-compliance status in documents submitted to the U.S. Securities and Exchange Commission.